The Netherlands: the Most Innovative Biopharmaceutical Community in Europe
The Netherlands has a world-leading Life Sciences & Health community. In this video, high level executives from the biopharmaceutical sector talk about the unique combination of Dutch strengths and the opportunities our country has to offer, such as the unrivalled concentration of biopharmaceutical ecosystems, our long history of public-private partnerships and our world-class infrastructure for drug research.
Onno van der Stolpe, CEO Galapagos: ‘For us the access to the academic infrastructure, the international workforce, the European Medicines Agency that relocated to Amsterdam and, of course, Schiphol are crucial for our success. The Netherlands is an excellent place to build your biotech company.’
We invite you to connect with our innovative Life Sciences and Health Community. We are ready to welcome you, open doors and roll out our orange carpet for you!3 June 2019